Abvc Biopharma, Inc. SEC filings ABVC
Abvc Biopharma, Inc. has 795 filings in SEC EDGAR's recent list, going back to Jun 28, 2002. Its latest annual report, Form 10-K, was filed on Mar 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (material agreement, agreement ended, new debt, unregistered share sale, shareholder vote results, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 18, 2026 | Mar 31, 2026 |
| 10-Q/A | Amended quarterly report | Mar 3, 2026 | Sep 30, 2025 |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | Apr 30, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 17, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 15, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 10, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 17, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | Jun 29, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 18, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 9, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 28, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 14, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 20, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 15, 2018 | Mar 31, 2018 |
| 10-Q/A | Amended quarterly report | Mar 19, 2018 | Jun 30, 2017 |
| 10-Q/A | Amended quarterly report | Mar 19, 2018 | Mar 31, 2017 |
| 10-Q/A | Amended quarterly report | Mar 19, 2018 | Dec 31, 2016 |
| 10-Q | Quarterly report | Aug 21, 2017 | Jun 30, 2017 |
| 10-Q/A | Amended quarterly report | May 22, 2017 | Dec 31, 2016 |
| 10-Q | Quarterly report | May 22, 2017 | Mar 31, 2017 |
| 10-Q/A | Amended quarterly report | Feb 22, 2017 | Jun 30, 2016 |
| 10-Q/A | Amended quarterly report | Feb 22, 2017 | Mar 31, 2016 |
| 10-Q | Quarterly report | Feb 21, 2017 | Dec 31, 2016 |
| 10-Q | Quarterly report | Aug 15, 2016 | Jun 30, 2016 |
| 10-Q/A | Amended quarterly report | May 17, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | May 16, 2016 | Mar 31, 2016 |
| 10-Q | Quarterly report | Feb 23, 2016 | Dec 31, 2015 |
| 10-Q | Quarterly report | Aug 19, 2015 | Jun 30, 2015 |
| 10-Q/A | Amended quarterly report | Jun 5, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | May 15, 2015 | Mar 31, 2015 |
| 10-Q | Quarterly report | Apr 17, 2015 | Dec 31, 2014 |
| 10-Q | Quarterly report | Apr 17, 2015 | Jun 30, 2014 |
| 10-Q | Quarterly report | Apr 17, 2015 | Mar 31, 2014 |
| 10-Q | Quarterly report | Apr 17, 2015 | Dec 31, 2013 |
| 10-Q | Quarterly report | Apr 16, 2015 | Jun 30, 2013 |
| 10-Q | Quarterly report | Apr 16, 2015 | Mar 31, 2013 |
| 10-Q | Quarterly report | Apr 16, 2015 | Dec 31, 2012 |
| 10-Q/A | Amended quarterly report | Aug 20, 2012 | Aug 17, 2012 |
| 10-Q | Quarterly report | Aug 14, 2012 | Aug 13, 2012 |
| 10-Q | Quarterly report | May 15, 2012 | May 14, 2012 |
| 10-Q | Quarterly report | Feb 21, 2012 | Feb 20, 2012 |
| 10-Q/A | Amended quarterly report | Sep 8, 2011 | Sep 8, 2011 |
| 10-Q | Quarterly report | Aug 15, 2011 | Aug 3, 2011 |
| 10-Q | Quarterly report | May 12, 2011 | May 12, 2011 |
| 10-Q | Quarterly report | Feb 14, 2011 | Feb 13, 2011 |
| 10-Q | Quarterly report | Aug 16, 2010 | Aug 15, 2010 |
| 10-Q/A | Amended quarterly report | Jul 7, 2010 | Jul 7, 2010 |
| 10-Q/A | Amended quarterly report | May 24, 2010 | May 21, 2010 |
| 10-Q/A | Amended quarterly report | May 24, 2010 | May 21, 2010 |
| 10-Q | Quarterly report | May 20, 2010 | May 20, 2010 |
| 10-Q/A | Amended quarterly report | Feb 17, 2010 | Feb 16, 2010 |
| 10-Q | Quarterly report | Feb 11, 2010 | Feb 11, 2010 |
| 10-Q/A | Amended quarterly report | Feb 11, 2010 | Feb 10, 2010 |
| 10-Q/A | Amended quarterly report | Feb 11, 2010 | Feb 8, 2010 |
| 10-Q/A | Amended quarterly report | Nov 10, 2009 | Nov 10, 2009 |
| 10-Q/A | Amended quarterly report | Sep 25, 2009 | Sep 25, 2009 |
| 10-Q | Quarterly report | Aug 19, 2009 | Aug 19, 2009 |
| 10-Q | Quarterly report | Apr 28, 2009 | Apr 28, 2009 |
| 10-Q | Quarterly report | Feb 11, 2009 | Dec 31, 2008 |
Showing 72 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABVC (Nasdaq), ECOC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fremont, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1173313
- Former names
- American BriVision (Holding) Corp (until Apr 8, 2021); METU BRANDS, INC. (until Jan 8, 2016); Ecology Coatings, Inc. (until Sep 2, 2015); ECOLOGY COATINGS, INC. (until Sep 2, 2015); OCIS CORP (until Jun 13, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.